Curriculum Vitae
Patrícia Barreto
Identificação
Identificação pessoal
- Nome completo
- Patrícia Barreto
Nomes de citação
- Barreto, Patrícia
Identificadores de autor
- Ciência ID
- 2313-D0C8-C843
Endereços de correio eletrónico
- pbarreto@aibili.pt (Profissional)
- patricia.s.barreto@gmail.com (Pessoal)
Domínios de atuação
- Ciências Médicas e da Saúde - Ciências da Saúde
Idiomas
| Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review |
|---|---|---|---|---|---|
| Português | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | |
| Inglês | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | Utilizador proficiente (C1) | |
| Espanhol; Castelhano | Utilizador independente (B1) | Utilizador independente (B1) | Utilizador elementar (A1) | Utilizador independente (B1) |
Formação
| Grau | Classificação | |
|---|---|---|
|
2018/09 - 2022
Em curso
|
Programa Doutoral em Ciências da Saúde (Doutoramento)
Especialização em Ciências Biomédicas
Universidade de Coimbra Faculdade de Medicina, Portugal
"Age-Related Macular Degeneration: Genetic Susceptibility, Nutrition and Lifestyle" (TESE/DISSERTAÇÃO)
|
|
|
2016
Concluído
|
Mestrado em Saúde Pública (Mestrado)
Universidade de Coimbra Faculdade de Medicina, Portugal
"Padrão Alimentar, Nutricional e Estilos de Vida Relacionados com a Degenerescência Macular Relacionada com a Idade na População
Portuguesa" (TESE/DISSERTAÇÃO)
|
18 |
|
2015/03/09 - 2015/03/13
Concluído
|
Advanced Course on Vision Sciences (Outros)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
18 |
|
2005
Concluído
|
Ciências Farmacêuticas (Licenciatura)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"n/a" (TESE/DISSERTAÇÃO)
|
13 |
Percurso profissional
Docência no Ensino Superior
| Categoria Profissional Instituição de acolhimento |
Empregador | |
|---|---|---|
| 2017 - Atual | Assistente convidado (Docente Ensino Superior Politécnico) | Instituto Politécnico do Porto, Portugal |
| Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
Outras Carreiras
| Categoria Profissional Instituição de acolhimento |
Empregador | |
|---|---|---|
| 2005/07/01 - 2008/12/01 | Técnico Farmacêutico 1 Cl (Técnico Farmacêutico) | Farmácia Loureiro, Portugal |
Outros
| Categoria Profissional Instituição de acolhimento |
Empregador | |
|---|---|---|
| 2013/12/01 - Atual | Assistente de Direção/Farmacêutica | Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal |
| 2010/07/01 - 2013/07/01 | Project Leader | Novexem Portugal, Portugal |
| 2009/01/01 - 2013/07/01 | Clinical Research Associate | Novexem Portugal, Portugal |
Projetos
Projeto
| Designação | Financiadores | |
|---|---|---|
| 2018 - Atual | Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive
Imaging methods, in a longitudinal, prospective and interventional clinical Study with 2 years of duration (CORDIS)
030375
Outra
|
Fundação para a Ciência e a Tecnologia
Em curso
|
| 2013 - 2017 | Do-Health: VitaminD3 –Omega3 –Home Exercise –HeALTHy Ageing and Longevity Randomized, double-blind, placebo-controlled, multi-centre
clinical trial
Do-Health
Outra
|
Concluído
|
| 2015 - 2016 | Metabolomics, Genetics and Environment – a novel integrative approach to Age-Related Macular Degeneration (PI: Inês Laíns).
Member of the research team. Participation in the study set up and management.
IN0654
Outra
Fundação para a Ciência e a Tecnologia, Portugal
|
Concluído
|
Outro
| Designação | Financiadores | |
|---|---|---|
| 2020 - Atual | A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH
DIABETIC MACULAR EDEMA
GR41987 / RHONE
Farmacêutico responsável
|
F Hoffmann-La Roche AG Research and Development Division
Em curso
|
| 2019 - Atual | A phase III, multicentre, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety
of RO6867461 in patients with diabetic macular edema (Rhine)
GR40398
|
Em curso
|
| 2019 - Atual | A two-year, three-arm, randomized, double-masked, multicentre, phase III study assessing the efficacy and safety of brolucizumab
versus aflibercept in adult patients with visual impairment due to diabetic macular edema (KESTREL)
CRTH258B2301
Outra
|
Em curso
|
| 2019 - Atual | A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy andSafety of Conbercept Intravitreal
Injection in Subjects with Neovascular Age-related Macular Subjects with Neovascular Age-related Macular Degeneration (PANDA)
KBH 1801
Outra
|
Em curso
|
| 2016/04 - Atual | STAR- Development of a Model for Advanced Screening for Timely Treatment of Age-Related Eye Diseases
CEC/008/2016
Outra
|
Em curso
|
| 2015 - Atual | An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of
2 mg aflibercept administered by intravitreal injections using two different treatment regimens to subjects with neovascular
age-related macular degeneration (nAMD) (AZURE)
16598
|
Em curso
|
| 2017 - 2018 | A Multicenter, open-label extension study to evaluate the long-term safty and tolerability of lampalizumab in patients with
geographic atrophy secondary to age-related macular degeneration who have completed a ROCHE- sponsored study (OMASPECT)
GX30191
Outra
|
Concluído
|
| 2016 - 2018 | A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6 mg Versus
Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration (HARRIER)
RTH258-C002
Outra
|
Concluído
|
| 2016 - 2018 | An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of
three different treatment regimens of 2 mg aflibercept administered by intravitreal injections to subjects with diabetic macular
edema (DME) (VIOLET)
17613
Outra
|
Concluído
|
| 2016 - 2018 | Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as monotherapy for patients with newly diagnosed partial-onset
seizures: a double-blind, randomized, active-controlled, parallel-group, multicenter clinical study
BIA-2093-311
Outra
|
Concluído
|
| 2015 - 2018 | A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab
administeredintravitreally to patients with geographic atrophy secondary to age-related macular degeneration (SPECTRI)
GX29185
Outra
|
Concluído
|
| 2015 - 2018 | A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept
Monotherapy Compared to Aflibercept with Adjunctive Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy
(ATLANTIC)
ECR-AMD-2015-09
Outra
|
|
| 2016 - 2017 | A randomized, double-masked, placebo-controlled exploratory study to evaluate pharmacodynamics, safety and tolerability of
orally administered BI 1026706 for 12 weeks in patients with mild visual impairment due to center-involved diabetic macular
edema (DME)
BI 1320.22
Outra
|
Concluído
|
| 2016 - 2017 | Five-year incidence of Age-related Macular Degeneration in the central region of Portugal
4C-2016-09
Outra
|
Concluído
|
| 2015 - 2017 | Estudo de intervenção em humanos, multicêntrico e aleatorizado, de suplementação nutricional em doentes com DMRI húmida unilateral
(RETILUT)
THEA-UNAV1/14
Outra
|
Concluído
|
| 2015 - 2017 | Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with diabetic macular edema (DME)
during treatment with intravitreal injections of 2 mg aflibercept according to EU the first year of treatmentlabel for the
first year of treatment (AQUA)
17850
Outra
|
Concluído
|
| 2014 - 2017 | A 12-month, phase IV, randomized, open label, multicenter study to compare efficacy of 0,5mg ranibizumab PRN versus 2 mg aflibercept
bimonthly intravitreal injections on retinal thickness stability till month 6 of treatment and explore functional outcomes
up to month 12 in patients w
CRFB002ADE23
Outra
|
Concluído
|
| 2014 - 2017 | OPH 1004: A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration
of fovista(anti pdgf-b pegylated aptamer) administered in combination with either avastin or eylea compared to avastin or
eylea monotherapy in subjects with subfovea
OPH1004
Outra
|
Concluído
|
| 2014 - 2016 | Prospective, randomized, multicentre, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg
intravitreal injections plus panretinal photocoagulation (PRP) versusPRP in monotherapy in the treatment of subjects withhigh
risk proliferative diabetic retinopathy (
ECR-RET-2013-05
Outra
|
Concluído
|
| 2013 - 2016 | SP0994 - A multicenter, double-blind, double-dummy, follow-up study evaluating the long-term safety of lacosamide (200 to
600mg/day) in comparison with carbamazepine (400 to 1200mg/day), used as monotherapy in subjects with partial-onset or generalized
tonic-clonic seizures =16 years of age coming f
SP0994
Outra
|
Concluído
|
| 2013 - 2016 | BIA-2093-311 - Efficacy and safety of Eslicarbazepine acetate (BIA 2-093) as monotheraphy for patients with newly diagnosed
partial-onset seizures: a double- blind, double-dummy, randomized, active-controlled, parallel- group, multicenter clinical
study.
BIA-2093-311
|
Concluído
|
| 2015 - 2015 | Genotypic and Phenotypic characterization of retinal angiomatous proliferation (RAP) lesions
CEC 006/2015
Outra
|
Concluído
|
| 2014 - 2015 | A non-randomised, open-label, multicenter phase 4 pilot study of the effect and safety of Iluvien® in chronic diabetic macular
edema patients considered insufficiently responsive to available therapie with or without intravitreal corticosteroid therapy.
4C-2014-06
Outra
|
Concluído
|
| 2014 - 2015 | A 12-month, phase IIIb, randomized, visual acuity assessor-masked, multicenter study assessing the efficacy and safety of
ranibizumab 0.5mg in treat and extend regimen compared to monthly regimen, in patients with neovascular age-related macular
degeneration (TREND)
CRFB002A2411
Outra
|
Concluído
|
| 2014 - 2015 | Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic
Vitreomacular Adhesion (JETREA)
M13-056
Outra
|
|
| 2013 - 2015 | Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy (EUROCONDOR)
4C-2011-02
Outra
|
Concluído
|
| 2013 - 2015 | A randomised, double-masked, placebo-controlled study of the efficacy of gevokizumab in the treatment of patients with Behçet’s
Disease Uveitis - EYEGUARD B
CL3-78989-002
|
Concluído
|
| 2013 - 2015 | A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active
Non-infectious Intermediate, Posterior, or Pan- Uveitis - EYEGUARD A
CL3-78989-005
Outra
|
Concluído
|
| 2013 - 2015 | Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion (BRVO)
CRFB002E2402
Outra
|
Concluído
|
| 2013 - 2015 | A 24-month, phase IIIb, randomized, double-masked, multicenter study assessing the efficacy and safety of two treatment regimens
of 0.5 mg ranibizumab intravitreal injections guided by functional and/or anatomical criteria, in patients with neovascular
age-related macular degeneration (OCTAVE)
CRFB002A2405
|
Concluído
|
| 2013 - 2015 | A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab
intravitreal injections in patients with visual impairment due to vascular endothelial growth factor (VEGF) driven choroidal
neovascularization (CNV) (MINERVA)
CRFB002G2301
Outra
|
|
| 2013 - 2015 | A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis
in Parkinson’s Disease
ACP-103-015
Outra
|
Concluído
|
| 2013 - 2015 | Efficacy and safety of 3 doses of S 38093 (2, 5 and 20 mg/day) versus placebo, in co-administration with donepezil (10 mg/day)
in patients with moderate Alzheimer’s Disease. A 24-week international, multi-centre, randomised, double-blind,placebo-controlled
phase IIb study
CL2-38093-012
Outra
|
Concluído
|
| 2013 - 2015 | A multicenter, double-blind, double-dummy, randomized, positive-controlled study comparing the efficacy and safety of lacosamide
(200 to 600 mg/day) to controlled release carbamazepine (400 to 1200 mg/day), used as monotherapy in subjects (=16 years)
newly or recently diagnosed with epilepsy and exp
SP0993
Outra
|
Concluído
|
| 2013 - 2015 | A Randomized, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Subjects
with Non-infectious IntermeDiate, Posterior, or Pan- uveitis Currently Controlled with Systemic Treatment (Eyeguard C)
CL3-78989-006
Outra
|
Concluído
|
| 2013 - 2015 | Efficacy and safety of BIA 9-1067 in idiopathic Parkinson’s disease patients with “wearing-off” phenomenon treated with levodopa
plus a dopa decarboxylase inhibitor (DDCI): a double-blind, randomised, placebo- and active-controlled, parallel-group, multic
BIA-91067
|
Concluído
|
| 2014 - 2014 | Intraocular pressure and tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or preservative free
Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost®) in patients with Ocular hypertension or glaucoma: A Randomized, single masked,
3 month cross-over, Investigator led, European mu
ECR-GLC-2013-06
Outra
|
Concluído
|
| 2013 - 2014 | Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein
Occlusion (CRVO)
CRFB002E2401
|
Concluído
|
| 2013 - 2014 | Multicenter, randomized, double-masked, 3 parallel arms, vehicle controlled, 4-month phase III trial with a 8 month safety
follow up period to evaluate the efficacy and safety of 2 dosing regimen of NOVA22007 1mg/ml (Ciclosporin/Cyclosporine) eye
drops, emulsion administered 4 times a day in
NVG09B113
Outra
|
Concluído
|
Produções
Publicações
| Artigo em revista |
|
| Tese / Dissertação |
|
Atividades
Apresentação oral de trabalho
| Título da apresentação | Nome do evento Anfitrião (Local do evento) |
|
|---|---|---|
| 2021/05 | Genetic characterization of a Portuguese age-related macular degeneration population | ARVO 2021
Association for Research in Vision and Ophthalmology (San Francisco & on line, Estados Unidos)
|
| 2021/05 | Characterization of risk phenotypes of type 2 diabetes nonproliferative retinopathy | ARVO 2021
Association for Research in Vision and Ophthalmology (San Francisco & online, Estados Unidos)
|
| 2021/05 | Characterization of one-year progression in risk phenotypes of diabetic retinopathy | ARVO 2021
Association for Research in Vision and Ophthalmology (San Francisco & online, Estados Unidos)
|
| 2021/05 | Common and rare genetic risk variants for Age-related Macular Degeneration progression in the Coimbra Eye Study. | ARVO 2021
Association for Research in Vision and Ophthalmology (São Francisco & Online, Estados Unidos)
|
| 2019/12 | ESTUDO CORDIS - UM ENSAIO LONGITUDINAL, PROSPETIVO E INTERVENCIONAL NUMA POPULAÇÃO DE DOENTES DIABÉTICOS TIPO 2 COM RETINOPATIA LIGEIRA A MODERADA | Sociedade Portuguesa de Oftalmologia - SPO
SPO (Portugal)
|
| 2019/12 | AGE-RELATED MACULAR DEGENERATION PREVALENCE AND STAGING BY COLOR FUNDUS PHOTOGRAPHY VS MULTIMODAL IMAGING. THE COIMBRA EYE STUDY | Congress of the SPO - Portuguese Ophthalmology Society
SPO (Portugal)
|
| 2018/03 | Estudo sobre a incidência da Degenerescência Macular Relacionada com a Idade aos cinco anos na região centro de Portugal. Simões C, Simão S, Lopes M, Santos AR, Barreto P, Ribeiro L, Silva R | XIX Congresso Nacional de Ortoptistas
Associação Portuguesa de Ortoptistas (Espinho, Portugal)
|
| 2017/09 | Food and Nutritional Pattern and Lifestyle related to Age-Related Macular Degeneration in Portugal. Barreto P, Laíns I, Alves D, Raimundo M, Santos L, Silva R | 17th Euretina Congress
EURETINA (Barcelona, Espanha)
|
| 2017/09 | Multimodal evaluation of the fellow eye of patients with retinal angiomatous proliferation. Martins A, Farinha C, Raimundo M, Lopes M, Melo P, Marques M, Marques JP, Barreto P, Cachulo ML, Neves C, Cunha-Vaz J, Silva R | 17th Euretina Congress
EURETINA (Barcelona, Espanha)
|
| 2016/12 | Age-related Macular Degeneration: an association with physical activity and lifestyle. | 59º Congresso Português e Oftalmologia
Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
|
| 2016/12 | Espessura da coróide na Degenerescência Macular relacionada com a Idade: a influência dos drusens reticulares. Providência J, Laíns I, Gil P, Gil J, Marques M, Barreto P, Mesquita T, Ribeiro L, Cachulo ML, Figueira J, Silva R | 59º Congresso Português e Oftalmologia
Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
|
| 2016/12 | Terapêutica no Edema Macular Diabético. Que Futuro? | 59º Congresso Português e Oftalmologia
Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
|
| 2016/11/09 | CEC - Clinical Trials Centre - AIBILI Clinical Trials in Ophthalmology. | Conferência APIFARMA 2016 "Investigação Clínica - Do Compromisso à Acção
APIFARMA (Lisboa, Portugal)
|
| 2016/10 | The Role of Adherence to a Mediterranean Diet and Lifestyle Risk Factors in AMD - The Coimbra Eye Study. | American Academy of Ophthamology
American Academy of Ophthamology (Chicago, Estados Unidos)
|
| 2016/10 | The Role of Reticular Pseudodrusen on Choroidal Thickness With Swept Source OCT . | American Academy of Ophthamology;
American Academy of Ophthamology; (Chicago, Estados Unidos)
|
| 2008/05 | Mental Health | 10th Congress of Young Pharmacists
(Opava, República Checa)
|
| 2008/05 | Pharmaceutical Education in Portugal | 10th Congress of Young Pharmacists
(Opava, República Checa)
|
Participação em evento
| Descrição da atividade Tipo de evento |
Nome do evento Instituição / Organização |
|
|---|---|---|
| 2020/10/24 - Atual | 15th EVICR.net Members Meeting 2020
Encontro
|
15th EVICR.net Members Meeting 2020
European Vision Institute Clinical Research Network , Portugal
|
| 2018/11/25 - Atual | Seminário no âmbito da Unidade Curricular de Desenvolvimento Farmacêutico, Licenciatura em Ciências Biomedical
Seminário
|
Clinical Research
Universidade de Aveiro, Portugal
|
| 2020/10/02 - 2020/10/04 | EURETINA 2020
Congresso
|
EURETINA 2020
EURETINA - The European Society of Retina Specialists, Irlanda
|
| 2020/07/10 - 2020/07/10 | Workshop em Boas Práticas Clínicas
Oficina (workshop)
|
Workshop em Boas Práticas Clínicas
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
|
| 2019/06/12 - 2019/06/12 | Clinical Research at a glance
Seminário
|
Clinical Research at a glance
iCBR - Coimbra Institute for Clinical and Biomedical Research, Portugal
|
Curso / Disciplina lecionado
| Disciplina | Curso (Tipo) | Instituição / Organização | |
|---|---|---|---|
| 2019/10/28 - 2019/10/28 | Workshop on Clinical Research | Mestrado em Investigação Biomédica (Mestrado) | Universidade de Coimbra Faculdade de Medicina, Portugal |
| 2019/05/31 - 2019/05/31 | Seminário/ Investigação Translacional em Oftalmologia. | Ortóptica (Licenciatura) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
| 2019/03/25 - 2019/03/25 | Seminário/ Clinical Research. | Biomedicina Farmacêutica (Licenciatura) | Universidade de Aveiro Departamento de Ciências Médicas, Portugal |
| 2018/03/16 - 2018/03/16 | Seminário - Investigação Translacional em Oftalmologia. | Ortóptica (Licenciatura) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
| 2016/05/21 - 2016/05/21 | Projecto / 21.05.2016. Investigação Clínica – a perspetiva do Investigador e contextualização legal. Class taught in the degree of Orthoptics at Escola Superior de Saúde do Porto. Porto, Portugal. Barreto P | Ortóptica (Licenciatura) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
Membro de associação
| Nome da associação | Tipo de participação | |
|---|---|---|
| 2005/08 - Atual | Ordem dos Farmacêuticos | Membro da Ordem dos Farmacêuticos |